LHV finantsportaal

Foorum Investeerimine

Börsipäev 10. august

Kommentaari jätmiseks loo konto või logi sisse

  • Ühendriikide aktsiaindeksid jätkasid eile vaikset tiksumist, lõpetades päeva pisikeses plussis (S&P 500 +0,04%). Aktiivsemaks kujunes sessioon Euroopas (Stoxx 600 +0,9%), kus investorite fookusesse jäi Inglise keskpanga nõukogu liikme Ian McCafferty kommentaar intressimäära edasise langetamise ning võlakirjade ostuprogrammi suurendamise võimalikkusest, kuigi viimasel oli juba eile raskusi vajalikus koguses Suurbritannia valitsuse pikaajaliste võlakirjade leidmisega. Euroopa aktsiaturgudest paistis eelkõige silma just Saksamaa, kus osade ettevõtete oodatust paremad tulemused aitasid DAX indeksil tõusta 2,5%, vähendades sellega kaotust alates aasta algusest -0,5%ni.

    USA väikefirmade kindlustunde indeks jäi juulis stabiilseks, kerkides eelmisel kuul vaid 0,1 punkti 94,6. Ettevõtete kindlustunne on alates aprillist liikunud ülesmäge, kuid 2015.a juuli ning terve eelmise aasta keskmisest jäi indeks siiski madalamaks (vastavalt 95,7 ning 96,1). Küsitlust koostava NFIBi peaökonomisti sõnul on väikefirmade seas määramatus kõrge, ootused tingimuste paranemiseks madalad ning investeeringute väljavaade nõrgapoolne, millest johtuvalt ei maksa oodata lähiajal ka indeksi suuremat hüpet.



    Majandusuudiste osas pakub tänane börsipäev statistikat, mis tõenäoliselt väga olulist mõju globaalsele sentimendile ei oma, kui Prantsusmaal avaldatakse juunikuu tööstustoodangu muutus ning Ühendriikides annab JOLTS küsitlus ülevaate vabade töökohtade arvust ja tööjõu liikumisest, kuid seda juuni kohta.

    09.45 Prantsusmaa tööstustoodang (juuni)
    10.30 Rootsi tööstustoodang ja tellimused (juuni)
    17.00 USA JOLTS tööturu küsitlus (juuni)
    17.30 USA toornafta varude raport (5. august)
    21.00 USA valitsuse eelarve (juuli)
  • Prantsusmaa töötleva tööstuse toodang kujunes arvatust märksa nõrgemaks, kahanedes juunis MoM -1,2% oodatud +0,2% kasvu asemel. Mullusega võrreldes kahanes toodang -1,5% (oodatid 0,1%).
  • UPGRADES:
    * Eldorado Gold (EGO) raised to buy at Goldman
    * Editas Medicine (EDIT) raised to buy at Jefferies
    * General Dynamics (GD) raised to outperform at Bernstein
    * Yelp (YELP) raised to outperform at Raymond James

    DOWNGRADES:
    * Ares Management (ARES) cut to neutral at BofAML
    * Atlassian (TEAM) cut to neutral at BTIG
    * Buffalo Wild Wings (BWLD) cut to marketperform at Raymond James
    * Camden Property (CPT) cut to neutral at Baird
    * Denbury Resources (DNR) cut to underweight at Barclays
    * Genpact (G) cut to underweight/in-line at Morgan Stanley
    * Jacobs Engineering (JEC) cut to neutral at UBS
    * Jones Energy (JONE) cut to underweight at Barclays
    * Myriad Genetics (MYGN) cut to neutral at Piper Jaffray
    * Cut to equalweight at Barclays
    * Cut to marketperform at Wells Fargo
    * RSP Permian (RSPP) cut to neutral/attractive at Goldman
    * Sovran Self Storage (SSS) cut to hold at Jefferies
    * SunPower (SPWR) cut to neutral at JPMorgan
    * Cut to market perform at Oppenheimer
    * Cut to hold at Deutsche Bank
    * Cut to neutral at Janney
    * Wayfair (W) cut to neutral at Goldman
    * Cut to neutral at BofAML

    INITIATIONS:
    * Fairmount Santrol (FMSA) rated new equalweight at Barclays
    * Lonestar Resources (LONE) rated new outperform at Cowen
    * U.S. Silica (SLCA) rated new overweight at Barclays
  • Gapping up
    In reaction to strong earnings/guidance:

    CLNE +19.2%, OPGN +15.4%, ADVM +12.7%, YELP +12.6%, SUNW +10.7%, VRNS +9.6%, DXPE +8.9%, BBSI +8.6%, COTV +7.7%, DHT +7.7%, NH +7.3%, YRD +7.3%, HCHC +7%, WATT +6.7%, (also announces $20 mln private placement), RL +6.6%, INFI +5.6%, CDXS +5.3%
    LITE +4.9%, HALO +4.8%, RYI +4.4%, JD +4.1%, XONE +3.7%, CEL +3.7%, OXLC +3.4%, HLIT +3.3%, CRME +3.2%, (also XYDALBA has been approved by the EMA for administration as a single, 30 minute, 1500mg infusion), AG +3.1%, ICLD +2.9%, CPRX +2.8%, ARMK +2.7%, PUK +2.5%, EDIT +2.4%, TCS +2.4%
    TAHO +1.9%, OTIV +1.8%, WAGE +1.7%, RBCN +1.7%, ICL +1.5%, PTLA +1.1%, AEZS +1.1%, IEC +1%
    Select metals/mining stocks trading higher: EGO +4.9%, MUX +4.4%, BTG +4%, GFI +3.9%, KGC +3.9%, SWC +3.3%, CDE +3.2%, HL +3.1%, FCX +3%, SLV +2.9%, ABX +2.8%, GDX +2.7%, GOLD +2.6%, AU +2.6%, GG +2.5%, AUY +2.3%, NEM +2.2%, MT +1.6%, BHP +1.5%, IAG +1.2%, GLD +1.1%

    Other news:
    APRI +27.9% (announces that Ferring Pharmaceuticals, the Company's new partner in Germany, has received the German marketing authorization for Vitaros)
    VTVT +15.5% (announces 'positive' topline results from a Phase 2b study of TTP399; achieves primary endpoint)
    CBMX +12.3% (announces that Universal Diagnostic Labs will market and distribute its chromosomal microarray miscarriage analysis test in both Northern and Southern California)
    VSAR +11.5% (Versartis and Teijin LImited enter into an exclusive license and supply agreement for the development and commercialization of somavaratan in Japan; will receive an upfront payment of $40 million )
    PLX +11.1% (announces additional 'positive' data from its phase I/II clinical trial of PRX-102 for the treatment of Fabry disease)
    OCN +7.9% (S&P raised its ranking on Ocwen Loan Servicing LLC Commercial Servicer, Ocwen Loan Servicing LLC Residential Master Servicer to Average)
    KTOV +6.8% (receives US patent for its lead drug candidate KIT-302)
    TOPS +5.9% (announces delivery of sixth newbuilding vessel & completion of six-vessel newbuilding program)
    JBLU +1.6% (reports July 2016 prelim traffic)
    Analyst comments:
    ZIOP +6.4% (upgraded to Market Perform from Underperform at Wells Fargo
    SSL +3.1% (upgraded to Overweight from Equal Weight at Morgan Stanley)
    ASPS +2.7% (upgraded to Buy at Compass Point)
    PHG +2.2% (upgraded to Buy from Neutral at UBS)
    Gapping down
    In reaction to disappointing earnings/guidance:

    GEVO -32.6%, MYGN -30%, SPWR -29%, (also announces restructuring due to industry conditions), WGBS -24.8%, TDW -17%, (updates status of discussions with lenders / noteholders ), PRGO -12.7%, YUME -10.2%
    SIF -9.4%, GALE -7%, CYBR -5.5%, DPLO -5.1%, LSCC -4.8%, ARWR -4.5%, OHRP -4.4%, CALL -4.3%, ALDX -4.2%, KORS -4.2%, SEDG -3.8%, OA -3.8%, WEN -3.8%, CALA -3.4%, VSAT -3.3%
    OMER -2.8%, SPPI -2.1%, NVAX -2%, HTM -1.8%, CTSO -1.8%, (thinly traded), DIS -1.4%, (also Acquires Minority Stake in BAMTech; Disney Investment will Accelerate Growth of Leading Technology and Direct-To-Consumer Video Streaming Company), MATR -1.4%, SPHS -1.4%, JAZZ -1%
    Other news:
    GBSN -9.1% (discloses further issuance of shares to certain holders of its 2015 Notes)
    RPRX -8.6% (light volume; enters into equity distribution agreement to offer and sell up to $10 mln in shares of common stock)
    CSIQ -5.5% (following SPWR earnings/guidance/restructuring news)
    X -4.2% (priced 18.9 mln shares common stock offering (upsized from 17 mln) at a public offering price of $23/share)
    FSLR -3.6% (following SPWR earnings/guidance/restructuring news)
    CLF -3.4% (announces underwritten public offering of $300 mln of its common shares)
    JKS -3.2% (in sympathy with SPWR earnings)
    ZBH -3.1% (pricing of a ~7.44 mln share secondary common stock offering at $129.75/share by selling shareholders)
    LY -2.9% (updates on Monarch 2 phase 3 trial of Abemaciclib; an independent Data Monitoring Committee recommended to continue the study without modification as the interim efficacy criteria were not me)
    VWR -2.8% ( commences 8 mln common stock offering by selling stockholder Varietal Distribution Holdings )
    LOAN -1.8% (prices underwritten public offering of 672,269 common shares at a price to the public of $5.95 per share)
    CONE -1.7% (CyrusOne commenced the public offering of 6.8 mln shares of common stock-including 3.4 mln by the Forward Purchaser or its affiliate in connection with the forward sale agreement )
    PANW -1.2% (following CYBR earnings)
    TSL -1.1% (following SPWR earnings/guidance/restructuring news)
    Analyst comments:
    NE -2.4% (downgraded to Sell from Hold at Argus)
    RBS -0.8% (downgraded to Hold from Buy at Investec)

    Briefing.com

Teemade nimekirja